Bayer wins US approval for stroke drug

Bayer has won US approval for its potential blockbuster stroke drug, according to Bloomberg. The approval follows the drug's earlier approval in China.

Detected & updated continuously · Source: Nebula

Story subjects

Bayer

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula